Toronto-Dominion Bank vs 22nd Century Group Inc — how do they compare? Toronto-Dominion Bank trades at $121.35 (market cap $200.48B), while 22nd Century Group Inc trades at $4.33 (market cap $1.52M). The key difference: Toronto-Dominion Bank is far larger — about 131894.7× 22nd Century Group Inc's market cap, and Toronto-Dominion Bank pays a 2.63% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| TD | XXII | |
|---|---|---|
Market Cap | $200.48B | $1.52M |
Sector | Financials | Technology |
52-Week High | $124.80 | $801.00 |
52-Week Low | $72.85 | $3.72 |
Dividend Yield | 2.63% | — |
Enterprise Value | — | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
TD trades at $123.38, up 1.9% today, with a bullish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q2 2026 EPS expected at $1.70. Revenue grew to $61.28 billion in 2025, and the net income margin improved to 33.51%. A dividend of $1.12 is scheduled for payment on July 31, 2026.
The outlook is positive, supported by strong earnings momentum and a unanimous analyst buy/hold consensus with no sell ratings. Key risks include volatile cash flows from operations and high leverage, with total liabilities of $1.95 trillion. The stock offers value with a P/E of 19.88 and robust profitability metrics like ROE of 12.59%.
XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.
The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.
Trailing returns across standard periods
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →